Is Cancer Solvable? Towards Efficient and Ethical Biomedical Science.

J Law Med Ethics

Jeff Shrager, Ph.D., is affiliated with xCures, Inc. and the Symbolic Systems Program, Stanford University. Mark Shapiro, M.A., M.B.A., is affiliated with xCures, Inc. and Pharma Initiatives Consulting, LLC. William Hoos, M.S., M.B.A., is affiliated with xCures, Inc.

Published: September 2019

Global Cumulative Treatment Analysis (GCTA) is a novel clinical research model combining expert knowledge, and treatment coordination based upon global information-gain, to treat every patient optimally while efficiently searching the vast space that is the realm of cancer research.

Download full-text PDF

Source
http://dx.doi.org/10.1177/1073110519876164DOI Listing

Publication Analysis

Top Keywords

cancer solvable?
4
solvable? efficient
4
efficient ethical
4
ethical biomedical
4
biomedical science
4
science global
4
global cumulative
4
cumulative treatment
4
treatment analysis
4
analysis gcta
4

Similar Publications

Motivation: Tumor trees, which depict the evolutionary process of cancer, provide a backbone for discovering recurring evolutionary processes in cancer. While they are not the primary information extracted from genomic data, they are valuable for this purpose. One such extraction method involves summarizing multiple trees into a single representative tree, such as consensus trees or supertrees.

View Article and Find Full Text PDF

SimCol3D - 3D reconstruction during colonoscopy challenge.

Med Image Anal

August 2024

Wellcome/EPSRC Centre for Interventional and Surgical Sciences (WEISS) and Department of Computer Science, University College London, London, UK.

Colorectal cancer is one of the most common cancers in the world. While colonoscopy is an effective screening technique, navigating an endoscope through the colon to detect polyps is challenging. A 3D map of the observed surfaces could enhance the identification of unscreened colon tissue and serve as a training platform.

View Article and Find Full Text PDF

Harnessing low dimensionality to visualize the antibody-virus landscape for influenza.

Nat Comput Sci

February 2023

Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.

Antibodies constitute a key line of defense against the diverse pathogens we encounter in our lives. Although the interactions between a single antibody and a single virus are routinely characterized in exquisite detail, the inherent tradeoffs between attributes such as potency and breadth remain unclear. Moreover, there is a wide gap between the discrete interactions of single antibodies and the collective behavior of antibody mixtures.

View Article and Find Full Text PDF

Current advances in niosomes applications for drug delivery and cancer treatment.

Mater Today Bio

December 2023

Laboratory for Biointerfaces, Empa, Swiss Federal Laboratories for Materials Science and Technology, 9014, St. Gallen, Switzerland.

The advent of nanotechnology has led to an increased interest in nanocarriers as a drug delivery system that is efficient and safe. There have been many studies addressing nano-scale vesicular systems such as liposomes and niosome is a newer generation of vesicular nanocarriers. The niosomes provide a multilamellar carrier for lipophilic and hydrophilic bioactive substances in the self-assembled vesicle, which are composed of non-ionic surfactants in conjunction with cholesterol or other amphiphilic molecules.

View Article and Find Full Text PDF

With today's pace of rapid technological advancement, many patient issues in modern medicine are increasingly solvable by mobile app solutions, which also have the potential to transform how clinical research is conducted. However, many critical challenges in the app development process impede bringing these translational technologies to patients, caused in large part by the lack of knowledge among clinicians and biomedical researchers of "what it takes" to design, develop, and maintain a successful medical app. Indeed, problems requiring mobile app solutions are often nuanced, requiring more than just clinical expertise, and issues such as the cost and effort required to develop and maintain a well-designed, sustainable, and scalable mobile app are frequently underestimated.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!